Contact
Please use this form to send email to PR contact of this press release:
FDA accepts proposal for reasonably likely surrogate endpoint for ‘MASH’ all-cause mortality or liver-related events
TO:
Please use this form to send email to PR contact of this press release:
FDA accepts proposal for reasonably likely surrogate endpoint for ‘MASH’ all-cause mortality or liver-related events
TO: